Int J Endocrinol Metab. 2017 Mar 09;15(2):e42649. doi: 10.5812/ijem.42649. eCollection 2017 Apr.
Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.
International journal of endocrinology and metabolism
Arash Ordookhani, Kenneth D Burman
Affiliations
Affiliations
- Endocrine Section, Department of Internal Medicine, Providence Hospital, Washington, DC, 20017.
- Endocrine Section, MedStar Washington Hospital Center, Washington, DC, 20010.
PMID: 29026409
PMCID: PMC5626118 DOI: 10.5812/ijem.42649
Abstract
CONTEXT: There are contradictory results on the effect of hypothyroidism on the changes in hemostasis. Inadequate population-based studies limited their clinical implications, mainly on the risk of venous thromboembolism (VTE). This paper reviews the studies on laboratory and population-based findings regarding hemostatic changes and risk of VTE in hypothyroidism and autoimmune thyroid disorders.
EVIDENCE ACQUISITION: A comprehensive literature search was conducted employing MEDLINE database. The following words were used for the search: Hypothyroidism; thyroiditis, autoimmune; blood coagulation factors; blood coagulation tests; hemostasis, blood coagulation disorders; thyroid hormones; myxedema; venous thromboembolism; fibrinolysis, receptors thyroid hormone. The papers that were related to hypothyroidism and autoimmune thyroid disorder and hemostasis are used in this review.
RESULTS: Overt hypothyroidism is more associated with a hypocoagulable state. Decreased platelet count, aggregation and agglutination, von Willebrand factor antigen and activity, several coagulation factors such as factor VIII, IX, XI, VII, and plasminogen activator-1 are detected in overt hypothyrodism. Increased fibrinogen has been detected in subclinical hypothyroidism and autoimmune thyroid disease rendering a tendency towards a hypercoagulability state. Increased factor VII and its activity, and plasminogen activator inhibitor-1 are among several findings contributing to a prothrombotic state in subclinical hypothyroidism.
CONCLUSIONS: Overt hypothyroidism is associated with a hypocoagulable state and subclinical hypothyroidism and autoimmune thyroid disorders may induce a prothrombotic state. However, there are contradictory findings for the abovementioned thyroid disorders. Prospective studies on the risk of VTE in various levels of hypofunctioning of the thyroid and autoimmune thyroid disorders are warranted.
Keywords: Blood Coagulation Factors; Fibrinolysis; Hashimoto Disease; Hypothyroidism; Myxedema; Thyroiditis, Autoimmune; Venous Thromboembolism
Conflict of interest statement
Conflict of Interest:None to declare.
References
- Vascul Pharmacol. 2010 Mar-Apr;52(3-4):151-6 - PubMed
- J Clin Endocrinol Metab. 2007 Jul;92(7):2415-20 - PubMed
- Eur J Endocrinol. 2004 Feb;150(2):125-31 - PubMed
- Endocr J. 2007 Feb;54(1):45-52 - PubMed
- Blood. 2008 Jan 15;111(2):643-50 - PubMed
- Int J Clin Pract. 2006 Jun;60(6):655-9 - PubMed
- Eur J Endocrinol. 2011 Apr;164(4):599-603 - PubMed
- Horm Metab Res. 1991 Dec;23(12):609-11 - PubMed
- Endocrine. 2006 Aug;30(1):63-7 - PubMed
- Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):221-6 - PubMed
- Scand J Clin Lab Invest. 1964;16:511-2 - PubMed
- Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1776-85 - PubMed
- Ann Intern Med. 2008 Jun 3;148(11):832-45 - PubMed
- Semin Thromb Hemost. 2011 Feb;37(1):35-40 - PubMed
- Semin Thromb Hemost. 2007 Nov;33(8):798-809 - PubMed
- BMC Med. 2011 Jan 10;9:1 - PubMed
- J Thromb Thrombolysis. 2010 Jan;29(1):87-91 - PubMed
- Thyroid. 2007 Nov;17(11):1075-84 - PubMed
- Blood Coagul Fibrinolysis. 2015 Apr;26(3):282-4 - PubMed
- Biomed Pharmacother. 2005 Jan-Feb;59(1-2):8-14 - PubMed
- Thromb Res. 2010 Jul;126(1):e61-2 - PubMed
- Endocrine. 2009 Feb;35(1):75-80 - PubMed
- Thromb Haemost. 2007 May;97(5):803-6 - PubMed
- Ann Intern Med. 1982 Nov;97(5):713-6 - PubMed
- Thromb Haemost. 1987 Dec 18;58(4):964-5 - PubMed
- J Endocrinol Invest. 2002 Apr;25(4):345-50 - PubMed
- Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9 - PubMed
- J Thromb Haemost. 2006 Sep;4(9):1886-90 - PubMed
- J Endocrinol Invest. 1988 Nov;11(10):723-5 - PubMed
- Biol Rev Camb Philos Soc. 2000 Nov;75(4):519-631 - PubMed
- Diabetes Res Clin Pract. 2006 Aug;73(2):150-7 - PubMed
- Int Immunopharmacol. 2008 Dec 20;8(13-14):1863-5 - PubMed
- J Clin Endocrinol Metab. 2007 Aug;92(8):3006-12 - PubMed
- Lancet. 2012 Jan 21;379(9812):244-9 - PubMed
- J Clin Endocrinol Metab. 2001 Feb;86(2):732-7 - PubMed
- Thromb Res. 1991 Dec 15;64(6):745-9 - PubMed
- Acta Haematol. 1978;59(3):171-7 - PubMed
- Br Med J. 1967 Oct 28;4(5572):147-8 - PubMed
- N Engl J Med. 2008 Aug 28;359(9):938-49 - PubMed
- Hematology. 2006 Jun;11(3):203-8 - PubMed
- J Clin Endocrinol Metab. 2002 Feb;87(2):489-99 - PubMed
- Thromb Haemost. 2006 Apr;95(4):750-1 - PubMed
- JAMA. 2000 Apr 19;283(15):2008-12 - PubMed
- Thromb Res. 2003 Jun 1;110(4):243-7 - PubMed
- Br Med J. 1965 Mar 13;1(5436):686-8 - PubMed
- J Lab Clin Med. 1987 Nov;110(5):576-82 - PubMed
- Semin Thromb Hemost. 2009 Apr;35(3):288-94 - PubMed
- J Clin Endocrinol Metab. 2004 Sep;89(9):4469-73 - PubMed
- Endocr J. 2005 Jun;52(3):363-7 - PubMed
- Haemophilia. 2014 May;20(3):326-32 - PubMed
- Lancet. 1987 May 2;1(8540):1007-9 - PubMed
- Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):50-7 - PubMed
- Thromb Haemost. 2013 Feb;109(2):214-20 - PubMed
- J Clin Endocrinol Metab. 2006 Feb;91(2):530-4 - PubMed
- Ann Intern Med. 1997 Apr 15;126(8):638-44 - PubMed
- Clin Appl Thromb Hemost. 2006 Jul;12(3):364-8 - PubMed
- Saudi Med J. 2008 Sep;29(9):1289-93 - PubMed
- J Endocrinol Invest. 2004 Dec;27(11):1065-71 - PubMed
- J Endocrinol Invest. 2004 Oct;27(9):886-92 - PubMed
- Blood Coagul Fibrinolysis. 1999 Dec;10(8):481-6 - PubMed
- Clin Appl Thromb Hemost. 2010 Feb;16(1):107-9 - PubMed
- Endocr Rev. 2008 Feb;29(1):76-131 - PubMed
- Acta Endocrinol (Copenh). 1992 May;126(5):399-403 - PubMed
- Br J Haematol. 2005 May;129(3):307-21 - PubMed
- Thromb Haemost. 1976 Jun 30;35(3):607-19 - PubMed
- Eur J Endocrinol. 2005 Mar;152(3):355-61 - PubMed
- Thromb Haemost. 1998 Jan;79(1):99-103 - PubMed
- J Thromb Haemost. 2006 Sep;4(9):1882-5 - PubMed
- Eur J Endocrinol. 2008 Aug;159(2):145-52 - PubMed
- Thyroid. 2011 Aug;21(8):837-43 - PubMed
- Acta Haematol. 1985;74(1):58-9 - PubMed
- Thromb Haemost. 1992 Jun 1;67(6):729 - PubMed
- Med Hypotheses. 2011 Jun;76(6):855-7 - PubMed
- Clin Appl Thromb Hemost. 2010 Oct;16(5):568-73 - PubMed
- Thromb Res. 2012 Apr;129(4):520-2 - PubMed
- Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):375-81 - PubMed
- Exp Clin Endocrinol Diabetes. 2010 Jun;118(6):381-7 - PubMed
- Clin Appl Thromb Hemost. 2009 Dec;15(6):676-80 - PubMed
- Thyroid. 2003 Oct;13(10):971-7 - PubMed
- J Thromb Haemost. 2012 Aug;10(8):1708-10 - PubMed
- Postgrad Med J. 1990 Apr;66(774):280-4 - PubMed
- Endocrinology. 2004 Jun;145(6):2804-14 - PubMed
- Eur J Clin Invest. 2001 Feb;31(2):131-7 - PubMed
- Endocrine. 2014 Aug;46(3):651-8 - PubMed
- Eur J Endocrinol. 1997 Jan;136(1):1-7 - PubMed
- Semin Thromb Hemost. 2011 Feb;37(1):7-10 - PubMed
- Int J Clin Pract. 2003 Mar;57(2):78-81 - PubMed
- Neurology. 2014 May 6;82(18):1643-52 - PubMed
- Endocrine. 2009 Aug;36(1):110-8 - PubMed
- Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S176-7 - PubMed
- J Neurol. 2008 Jul;255(7):962-6 - PubMed
- Clin Endocrinol (Oxf). 2004 Aug;61(2):232-8 - PubMed
- Intern Med. 2009;48(5):281-5 - PubMed
- J Clin Res Pediatr Endocrinol. 2012 Sep;4(3):146-50 - PubMed
- Thromb Haemost. 1976 Apr 30;35(2):415-22 - PubMed
- N Engl J Med. 1965 Nov 11;273(20):1057-61 - PubMed
- Stroke. 2005 Oct;36(10):2302-10 - PubMed
Publication Types